Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The SANT study
2019-000756-34Phase 4Active
- Sponsor
- Region Jönköpings Län
- Start
- Apr 2019
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of phenoxymethylpenicillin in Acute pharyngotonsillitis (APT) (2 arms), sponsored by Region Jönköpings Län. Primary endpoint: Time to resolution of symptoms. Started Apr 2019; status: active.
02
Drugs
phenoxymethylpenicillin
03
Conditions
Acute pharyngotonsillitis (APT)
Beyond the preview
Go deeper on 2019-000756-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000756-34.